← Back to Search

Tailored Adherence Program for Young Adults with Cancer

N/A
Recruiting
Led By Meghan E McGrady, PhD
Research Sponsored by Children's Hospital Medical Center, Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient prescribed oral chemotherapy or prophylactic medication
Patient between 15 and 24 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up end of study enrollment period, approximately 12 months after enrollment initiation
Awards & highlights

Study Summary

This trial will test a tailored program for 40 young adults with cancer to see if it meets criteria and is easy/acceptable to use.

Who is the study for?
This trial is for adolescents and young adults aged 15-24 with cancer who are prescribed oral chemotherapy or prophylactic medication. They must be fluent in English without significant cognitive deficits, as judged by their medical team, and willing to use an electronic monitoring device. Those already showing high adherence (95% or more) during a preliminary period won't qualify.Check my eligibility
What is being tested?
The study tests a tailored program against the standard uniform care to improve medication adherence in young cancer patients. It's designed to see if the new approach is feasible, easy to use, acceptable, and meets certain criteria regarding enrollment, retention, fidelity of implementation, and data completion.See study design
What are the potential side effects?
Since this trial focuses on improving adherence rather than testing new medications, side effects will relate primarily to the existing medications being taken by participants rather than from the interventions themselves.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am taking oral chemotherapy or medication to prevent illness.
Select...
I am between 15 and 24 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~end of study enrollment period, approximately 12 months after enrollment initiation
This trial's timeline: 3 weeks for screening, Varies for treatment, and end of study enrollment period, approximately 12 months after enrollment initiation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Enrollment Rate
Secondary outcome measures
Acceptability & Adherence Scale
Adjective Rating Scale
Assessment Completion
+8 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Tailored ProgramExperimental Treatment1 Intervention
8-week tailored program including 4 coach visits and 4 bi-weekly text check-ins
Group II: Feedback ProgramExperimental Treatment1 Intervention
8-week feedback program including 8 weekly texts

Find a Location

Who is running the clinical trial?

Children's Hospital Medical Center, CincinnatiLead Sponsor
814 Previous Clinical Trials
6,531,541 Total Patients Enrolled
St. Jude Children's Research HospitalOTHER
427 Previous Clinical Trials
5,306,537 Total Patients Enrolled
Seattle Children's HospitalOTHER
299 Previous Clinical Trials
5,216,769 Total Patients Enrolled

Media Library

Feedback Program Clinical Trial Eligibility Overview. Trial Name: NCT05706610 — N/A
Cancer Clinical Trial 2023: Feedback Program Highlights & Side Effects. Trial Name: NCT05706610 — N/A
Cancer Research Study Groups: Tailored Program, Feedback Program
Feedback Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT05706610 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals who are below the age of 80 being admitted to this medical trial?

"Participants must be between 15 and 24 years old in order to qualify for this clinical trial."

Answered by AI

What are the eligibility criteria for participation in this trial?

"This clinical trial is welcoming 40 individuals aged 15-24 who have been diagnosed with cancer and are currently taking oral chemotherapy or prophylactic medication. It is essential that applicants meet these criteria before applying for the study."

Answered by AI

Are there any vacancies to join this scientific exploration?

"According to the clinicaltrials.gov database, this study is not presently accepting new participants. Initially posted on February 6th 2023 and last edited January 20th 2023, it appears that recruitment has ended for the time being. There are still 556 other trials actively seeking patients at present though."

Answered by AI
~15 spots leftby Nov 2024